Soleno Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Redwood City, California, dedicated to creating innovative therapies for rare diseases. Leveraging its proprietary drug development platform, Soleno is focused on addressing significant unmet medical needs through its advanced clinical trials. With a strong emphasis on rare diseases, the company represents a compelling investment opportunity for institutional investors seeking to engage with cutting-edge biopharmaceutical advancements and capitalize on emerging market possibilities. Show more

Location: 100 MARINE PARKWAY, REDWOOD CITY, CA, UNITED STATES, 94065, Redwood City, CA, 94065, USA | Website: https://soleno.life | Industry: BIOTECHNOLOGY | Sector: HEALTHCARE


Market Cap

2.071B

52 Wk Range

$37.95 - $90.32

Previous Close

$38.56

Open

$39.88

Volume

2,183,962

Day Range

$39.51 - $42.73

Enterprise Value

1.625B

Cash

246.7M

Avg Qtr Burn

N/A

Insider Ownership

2.00%

Institutional Own.

-

Qtr Updated

09/30/25


Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.